BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saviano A, Tripon S, Baumert TF. FIB-4 score and hepatocellular carcinoma risk after hepatitis C virus cure: time to revise surveillance? Hepatobiliary Surg Nutr 2020;9:661-4. [PMID: 33163519 DOI: 10.21037/hbsn.2020.01.05] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Huynh T, Ma S, Hu KQ. HCV direct acting antiviral treatment leads to highly durable rates of ALT and AST lower than 30/19 criteria and improved APRI and FIB-4 scores. Hepatol Commun 2022;6:3496-504. [PMID: 36221305 DOI: 10.1002/hep4.2098] [Reference Citation Analysis]